Tag: FDA

The Food and Drug Administration has approved a first-of-its-kind treatment for vitiligo, a condition that causes patches of discoloration on the skin and, currently, has few other therapeutic options. The treatment, known as ruxolitinib, is now the only one approved in the U.S. to repigment skin in people with the most common, “nonsegmental” form of […]